{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:42:44Z","timestamp":1764002564082,"version":"3.40.5"},"reference-count":21,"publisher":"Sociedade Brasileira de Cardiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,3]]},"DOI":"10.36660\/abc.20210770","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T19:15:01Z","timestamp":1664824501000},"source":"Crossref","is-referenced-by-count":2,"title":["Teste de Limiar de Desfibrila\u00e7\u00e3o e Seguimento a Longo Prazo de Pacientes com Cardiopatia Cr\u00f4nica da Doen\u00e7a de Chagas"],"prefix":"10.36660","author":[{"given":"Marco Paulo Cunha","family":"Campos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Fernando Gouveia","family":"Bernardes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Paulo Chaves de","family":"Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Corsino dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano Hon\u00f3rio Ribeiro","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6963-3776","authenticated-orcid":false,"given":"Maria Licia Ribeiro Cury","family":"Pav\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elerson","family":"Arfelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Filho","given":"Adilson","family":"Scorzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Anis","family":"Rassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Marin-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1090-8165","authenticated-orcid":false,"given":"Andr\u00e9","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22636","reference":[{"issue":"12","key":"key20221003151457_B1","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1161\/CIR.0000000000000599","article-title":"Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association","volume":"138","author":"Nunes","year":"2018","unstructured":"1. Nunes MCP, Beaton A, Acquatella H, Bern C, Bolger AF, Echeverria LE, et al. Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association. Circulation. 2018;138(12):e169-e209. doi: 10.1161\/CIR.0000000000000599.","journal-title":"Circulation"},{"issue":"10","key":"key20221003151457_B2","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.jacep.2019.07.003","article-title":"Systematic Review and Meta-Analysis of Clinical Outcome After Implantable Cardioverter-Defibrillator Therapy in Patients With Chagas Heart Disease","volume":"5","author":"Rassi","year":"2019","unstructured":"2. Rassi FM, Minohara L, Rassi Jr A, Correia LCL, Marin-Neto JA, Rassi A, da Silva Menezes A, Jr. Systematic Review and Meta-Analysis of Clinical Outcome After Implantable Cardioverter-Defibrillator Therapy in Patients With Chagas Heart Disease. JACC Clin Electrophysiol. 2019;5(10):1213-23. doi: 10.1016\/j.jacep.2019.07.003.","journal-title":"JACC Clin Electrophysiol"},{"issue":"9","key":"key20221003151457_B3","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/eut092","article-title":"Another disappointing result with implantable cardioverter-defibrillator therapy in patients with Chagas disease","volume":"15","author":"Rassi","year":"2013","unstructured":"3. Rassi A Jr, Rassi A. Another disappointing result with implantable cardioverter-defibrillator therapy in patients with Chagas disease. Europace : 2013;15(9):1383. doi: 10.1093\/europace\/eut092","journal-title":"Europace"},{"issue":"6","key":"key20221003151457_B4","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ahj.2013.08.027","article-title":"CHronic use of Amiodarone aGAinSt Implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy Study: rationale and design of a randomized clinical trial","volume":"166","author":"Martinelli","year":"2013","unstructured":"4. Martinelli M, Rassi A Jr Marin-Neto JA, de Paola AA, Berwanger O, Scanavacca MI, et al. CHronic use of Amiodarone aGAinSt Implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy Study: rationale and design of a randomized clinical trial. Am Heart J.2013;166(6):976-82.e.4 doi: 10.1016\/j.ahj.2013.08.027","journal-title":"Am Heart J"},{"issue":"1","key":"key20221003151457_B5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1590\/S0066-782X2001000100008","article-title":"Sudden death in Chagas\u2019 disease","volume":"76","author":"Rassi","year":"2001","unstructured":"5. Rassi Jr A, Rassi SG, Rassi A. Sudden death in Chagas\u2019 disease. Arq Bras Cardiol.2001;76(1):75-96. doi: 10.1590\/s0066-782x2001000100008.","journal-title":"Arq Bras Cardiol"},{"issue":"5","key":"key20221003151457_B6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/europace\/eut422","article-title":"Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas\u2019 heart disease: comparison with a control group treated with amiodarone alone","volume":"16","author":"Gali","year":"2014","unstructured":"6. Gali WL, Sarabanda AV, Baggio JM, Ferreira LG, Gomes GG, Marin-Neto J\u00c1, Junqueira LF. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas\u2019 heart disease: comparison with a control group treated with amiodarone alone. Europace : 2014;16(5):674-80. doi: 10.1093\/europace\/euz012.","journal-title":"Europace"},{"issue":"7","key":"key20221003151457_B7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/europace\/eut011","article-title":"Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease","volume":"15","author":"Barbosa","year":"2013","unstructured":"7. Barbosa MP, da Costa Rocha MO, de Oliveira AB, Lombardi F, Ribeiro AL. Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease. Europace. 2013;15(7):957-62. doi: 10.1093\/europace\/eut011.","journal-title":"Europace"},{"issue":"5","key":"key20221003151457_B8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/pace.12838","article-title":"Reassessing Risk Factors for High Defibrillation Threshold: The EF-SAGA Risk Score and Implications for Device Testing. Pacing and clinical electrophysiology","volume":"39","author":"Shih","year":"2016","unstructured":"8. Shih MJ, Kakodkar SA, Kaid Y, Hassel JL, Yarlagadda S, Fogg LF, et al. Reassessing Risk Factors for High Defibrillation Threshold: The EF-SAGA Risk Score and Implications for Device Testing. Pacing and clinical electrophysiology. Pacing Clin Electrophysiol.2016;39(5):483-9. doi: 10.1111\/pace.12838.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"3","key":"key20221003151457_B9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.hrthm.2007.11.018","article-title":"Complications associated with defibrillation threshold testing: the Canadian experience","volume":"5","author":"Birnie","year":"2008","unstructured":"9. Birnie D, Tung S, Simpson C, Crystal E, Exner D, Ayala Paredes FA, et al. Complications associated with defibrillation threshold testing: the Canadian experience. Heart Rhythm.2008;5(3):387-90. doi: 10.1016\/j.hrthm.2007.11.018","journal-title":"Heart Rhythm"},{"issue":"2","key":"key20221003151457_B10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCEP.113.000371","article-title":"Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation","volume":"7","author":"Russo","year":"2014","unstructured":"10. Russo AM, Chung MK. Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation. Circ Arrhythm Electrophysiol.. 2014;7(2):337-46. doi: 10.1161\/CIRCEP.113.000371.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"key20221003151457_B11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/CIRCEP.113.000373","article-title":"Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing should not be routinely performed at the time of implantable cardioverter defibrillator implantation","volume":"7","author":"Healey","year":"2014","unstructured":"11. Healey JS, Brambatti M. Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing should not be routinely performed at the time of implantable cardioverter defibrillator implantation. Circ Arrhythm Electrophysiol. 2014;7(2):347-51. doi: 10.1016\/S0140-6736(14)61903-6.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"9970","key":"key20221003151457_B12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(14)61903-6","article-title":"Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE)","volume":"385","author":"Healey","year":"2015","unstructured":"12. Healey JS, Hohnloser SH, Glikson M, Neuzner J, Mabo P, Vinolas X, et al.. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE). Lancet. 2015;385(9970):785-91. doi: 10.1016\/S0140-6736(14)61903-6","journal-title":"Lancet"},{"issue":"37","key":"key20221003151457_B13","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1093\/eurheartj\/ehv292","article-title":"Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial","volume":"36","author":"Bansch","year":"2015","unstructured":"13. Bansch D, Bonnemeier H, Brandt J, Bode F, Svendsen JH, Taborsky M, et al. Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial. Eur Heart J. 2015;36(37):2500-7. doi: 10.1093\/eurheartj\/ehv292.","journal-title":"Eur Heart J"},{"issue":"3","key":"key20221003151457_B14","first-page":"160","article-title":"ICD patients with elevated defibrillation threshold: clinical behavior and therapeutic alternatives","volume":"90","author":"Lima","year":"2008","unstructured":"14. Lima CE, Martinelli Filho M, Silva RT, Tamaki WT, Oliveira JC, Martins DC, et al. ICD patients with elevated defibrillation threshold: clinical behavior and therapeutic alternatives. Arq Bras Cardiol. 2008;90(3):160-6. doi: 10.1590\/s0066-782x2008000300004.","journal-title":"Arq Bras Cardiol"},{"issue":"6","key":"key20221003151457_B15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/pace.13333","article-title":"Long-term follow-up of Chagas heart disease patients receiving an implantable cardioverter-defibrillator for secondary prevention","volume":"41","author":"Pavao","year":"2018","unstructured":"15. Pavao M, Arfelli E, Scorzoni-Filho A, Rassi Jr A, Pazin-Filho A, Pavao RB, et al. Long-term follow-up of Chagas heart disease patients receiving an implantable cardioverter-defibrillator for secondary prevention. Pacing Clin Electrophysiol.. 2018;41(6):583-8. doi: 10.1111\/pace.13333","journal-title":"Pacing Clin Electrophysiol"},{"issue":"8","key":"key20221003151457_B16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa053241","article-title":"Development and validation of a risk score for predicting death in Chagas\u2019 heart disease","volume":"355","author":"Rassi","year":"2006","unstructured":"16. Rassi Jr A, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, et al. Development and validation of a risk score for predicting death in Chagas\u2019 heart disease. N Engl J Med. 2006;355(8):799-808. doi: 10.1056\/NEJMoa053241.","journal-title":"N Engl J Med"},{"issue":"8","key":"key20221003151457_B17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jacc.2013.09.079","article-title":"Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry)","volume":"63","author":"Dodson","year":"2014","unstructured":"17. Dodson JA, Reynolds MR, Bao H, Al-Khatib SM, Peterson ED, Kremers MS, et al. Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry).J Am Coll Cardiol. 2014;63(8):788-96. doi: 10.1016\/j.jacc.2013.09.079","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"key20221003151457_B18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.15420\/aer.2018.54.2","article-title":"Defibrillation Threshold Testing: Current Status","volume":"7","author":"Hayase","year":"2018","unstructured":"18. Hayase J, Do DH, Boyle NG. Defibrillation Threshold Testing: Current Status. Arrhythm Electrophysiol Rev . 2018;7(4):288-93. doi: 10.15420\/aer.2018.54.2.","journal-title":"Arrhythm Electrophysiol Rev"},{"issue":"1","key":"key20221003151457_B19","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000198","article-title":"A systematic review of ICD complications in randomised controlled trials versus registries: is our \u2018real-world\u2019 data an underestimation?","volume":"2","author":"Ezzat","year":"2015","unstructured":"19. Ezzat VA, Lee V, Ahsan S, Chow AW, Segal O, Rowland E, et al. A systematic review of ICD complications in randomised controlled trials versus registries: is our \u2018real-world\u2019 data an underestimation? Open Heart. 2015;2(1):e000198. doi: 10.1136\/openhrt-2014-000198.","journal-title":"Open Heart"},{"issue":"2","key":"key20221003151457_B20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/europace\/eun325","article-title":"Implantable cardioverter defibrillators and Chagas\u2019 disease: results of the ICD Registry Latin America","volume":"11","author":"Muratore","year":"2009","unstructured":"20. Muratore CA, Batista Sa LA, Chiale PA, Eloy R, Tentori MC, Escudero J, et al. Implantable cardioverter defibrillators and Chagas\u2019 disease: results of the ICD Registry Latin America. Europace. 2009;11(2):164-8. doi: 10.1093\/europace\/eun325.","journal-title":"Europace"},{"issue":"10","key":"key20221003151457_B21","first-page":"1238","article-title":"Electrical Storm in Chagas Cardiomyopathy: Clinical Predictors, Outcome, and Arrhythmic Characteristics in a Prospective Registry","volume":"6","author":"Ribeiro Cury Pavao","year":"2020","unstructured":"21. Ribeiro Cury Pavao ML, Arfelli E, Scorzoni-Filho A, Pavao RB, Pazin-Filho A, et al. Electrical Storm in Chagas Cardiomyopathy: Clinical Predictors, Outcome, and Arrhythmic Characteristics in a Prospective Registry. JACC Clin Electrophysiol. 2020;6(10):1238-45. doi: 10.1016\/j.jacep.2020.04.028","journal-title":"JACC Clin Electrophysiol"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/abccardiol.org\/article\/teste-de-limiar-de-desfibrilacao-e-seguimento-a-longo-prazo-de-pacientes-com-cardiopatia-cronica-da-doenca-de-chagas\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:10:43Z","timestamp":1747401043000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/teste-de-limiar-de-desfibrilacao-e-seguimento-a-longo-prazo-de-pacientes-com-cardiopatia-cronica-da-doenca-de-chagas\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":21,"alternative-id":["10.36660\/abc.20210770"],"URL":"https:\/\/doi.org\/10.36660\/abc.20210770","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"type":"print","value":"0066-782X"},{"type":"electronic","value":"1678-4170"}],"subject":[],"published":{"date-parts":[[2022,10,3]]}}}